Lower Galilee, Israel

Yuval Evron


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuval Evron: Innovator in Pharmaceutical Chemistry

Introduction

Yuval Evron is a notable inventor based in Lower Galilee, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis and purification of warfarin compounds. His innovative work has implications for the production of anticoagulant medications.

Latest Patents

Yuval Evron holds a patent for a "Process for synthesis of pure warfarin acid, warfarin alkali metal salts and corresponding clathrates." This patent describes an improved procedure for the purification of warfarin acid. The process allows for the preparation of sodium, potassium, and lithium warfarin salts, as well as their corresponding clathrates, in high pharmacopoeial grade purity and good yields. This advancement is crucial for ensuring the quality and efficacy of warfarin-based medications.

Career Highlights

Evron is associated with Taro Pharmaceutical Industries Limited, where he applies his expertise in pharmaceutical development. His work focuses on enhancing the production processes of essential medications, contributing to the overall improvement of healthcare solutions.

Collaborations

Yuval has collaborated with notable colleagues, including Sorin Bercovici and Osvaldo Fuxman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.

Conclusion

Yuval Evron's contributions to the field of pharmaceutical chemistry, particularly through his patent on warfarin synthesis, highlight his role as an innovator in the industry. His work not only advances pharmaceutical processes but also enhances the quality of medications available to patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…